Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0420 Transporter Info | ||||
Gene Name | SLC5A11 | ||||
Transporter Name | Sodium/myo-inositol cotransporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Approved Drug |
|||||
Phenobarbital |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Phenobarbital increases the expression of SLC5A11 | [1] | |||
Copper Sulfate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Copper Sulfate increases the expression of SLC5A11 | [2] | |||
Rifampin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Rifampin increases the expression of SLC5A11 | [3] | |||
Urethane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Urethane inhibits the expression of SLC5A11 | [4] | |||
Drug in Phase 3 Trial |
|||||
Triclosan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Triclosan increases the expression of SLC5A11 | [10] | |||
Drug in Phase 2 Trial |
|||||
Bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol A inhibits the expression of SLC5A11 | [6] | |||
Drug in Preclinical Test |
|||||
(+)-JQ1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
(+)-JQ1 inhibits the expression of SLC5A11 | [9] | |||
Natural Product |
|||||
Methyleugenol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Methyleugenol increases the expression of SLC5A11 | [11] | |||
Mycotoxins |
|||||
Aflatoxin B1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 inhibits the expression of SLC5A11 | [5] | |||
Carcinogen |
|||||
Benzo(a)pyrene |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene increases the expression of SLC5A11 | [12] | |||
Health and Environmental Toxicant |
|||||
Butyraldehyde |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Butyraldehyde inhibits the expression of SLC5A11 | [7] | |||
tris(1,3-dichloro-2-propyl)phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of SLC5A11 | [8] | |||
Chemical Compound |
|||||
Pentanal |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Pentanal inhibits the expression of SLC5A11 | [7] | |||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of SLC5A11 5' UTR | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Benzo(a)pyrene affects the methylation of SLC5A11 exon | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Benzo(a)pyrene affects the methylation of SLC5A11 promoter | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
abrine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
abrine results in decreased expression of SLC5A11 mRNA | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Aldehydes |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aldehydes results in decreased expression of SLC5A11 mRNA | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
aristolochic acid I |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
aristolochic acid I results in increased expression of SLC5A11 mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A results in decreased expression of SLC5A11 mRNA | [6] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
butyraldehyde |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
butyraldehyde results in decreased expression of SLC5A11 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
CGP 52608 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
CGP 52608 promotes the reaction RORA protein binds to SLC5A11 gene | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
methyleugenol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
methyleugenol results in increased expression of SLC5A11 mRNA | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
N-Nitrosopyrrolidine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
N-Nitrosopyrrolidine results in increased expression of SLC5A11 mRNA | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Okadaic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Okadaic Acid results in increased expression of SLC5A11 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
pentanal |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
pentanal results in decreased expression of SLC5A11 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
propionaldehyde |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
propionaldehyde results in decreased expression of SLC5A11 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
S-(1,2-dichlorovinyl)cysteine |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides which results in increased expression of SLC5A11 mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides results in increased expression of SLC5A11 mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
S-(1,2-dichlorovinyl)cysteine results in increased expression of SLC5A11 mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Silicon Dioxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Silicon Dioxide analog results in decreased expression of SLC5A11 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite affects the methylation of SLC5A11 gene | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
sodium arsenite results in increased expression of SLC5A11 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Thiram |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Thiram results in increased expression of SLC5A11 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.